Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results (Q46056351)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results |
scientific article |
Statements
1 reference
Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results (English)
1 reference
Manuel D Cerqueira
1 reference
Patricia Nguyen
1 reference
Peter Staehr
1 reference
S Richard Underwood
1 reference
Ami E Iskandrian
1 reference
ADVANCE-MPI Trial Investigators
1 reference
1 May 2008
1 reference
1
1 reference
3
1 reference
307-316
1 reference
Identifiers
1 reference